These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 21584927)

  • 1. Does a patient qualify for liver transplantation after the down-staging of hepatocellular carcinoma?
    Yao FY; Breitenstein S; Broelsch CE; Dufour JF; Sherman M
    Liver Transpl; 2011 Oct; 17 Suppl 2():S109-16. PubMed ID: 21584927
    [No Abstract]   [Full Text] [Related]  

  • 2. Tools for monitoring patients with hepatocellular carcinoma on the waiting list and after liver transplantation.
    Kneteman N; Livraghi T; Madoff D; de Santibañez E; Kew M
    Liver Transpl; 2011 Oct; 17 Suppl 2():S117-27. PubMed ID: 21584926
    [No Abstract]   [Full Text] [Related]  

  • 3. What is the best staging system for hepatocellular carcinoma in the setting of liver transplantation?
    Olthoff KM; Forner A; Hübscher S; Fung J
    Liver Transpl; 2011 Oct; 17 Suppl 2():S26-33. PubMed ID: 21656653
    [No Abstract]   [Full Text] [Related]  

  • 4. Is the treatment of hepatocellular carcinoma on the waiting list necessary?
    Majno P; Lencioni R; Mornex F; Girard N; Poon RT; Cherqui D
    Liver Transpl; 2011 Oct; 17 Suppl 2():S98-108. PubMed ID: 21954097
    [No Abstract]   [Full Text] [Related]  

  • 5. Is tumor biopsy necessary?
    Müllhaupt B; Durand F; Roskams T; Dutkowski P; Heim M
    Liver Transpl; 2011 Oct; 17 Suppl 2():S14-25. PubMed ID: 21744470
    [No Abstract]   [Full Text] [Related]  

  • 6. Neoadjuvant therapies for hepatocellular carcinoma before liver transplantation: a critical appraisal.
    Lopez PM; Villanueva A; Roayaie S; Llovet JM
    Liver Transpl; 2006 Dec; 12(12):1747-54. PubMed ID: 17133591
    [No Abstract]   [Full Text] [Related]  

  • 7. Should the liver transplant criteria for hepatocellular carcinoma be different for deceased donation and living donation?
    Grant D; Fisher RA; Abecassis M; McCaughan G; Wright L; Fan ST
    Liver Transpl; 2011 Oct; 17 Suppl 2():S133-8. PubMed ID: 21634006
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of recurrent hepatocellular carcinoma after liver transplantation.
    Davis E; Wiesner R; Valdecasas J; Kita Y; Rossi M; Schwartz M
    Liver Transpl; 2011 Oct; 17 Suppl 2():S162-6. PubMed ID: 21688382
    [No Abstract]   [Full Text] [Related]  

  • 9. Should we perform deceased donor liver transplantation after living donor liver transplantation has failed?
    Greig PD; Geier A; D'Alessandro AM; Campbell M; Wright L
    Liver Transpl; 2011 Oct; 17 Suppl 2():S139-46. PubMed ID: 21563294
    [No Abstract]   [Full Text] [Related]  

  • 10. Reply: selection criteria for liver transplantation in patients with hepatocellular carcinoma: beyond tumor size and number?
    Otto G
    Liver Transpl; 2007 Mar; 13(3):470-1. PubMed ID: 17318868
    [No Abstract]   [Full Text] [Related]  

  • 11. Markers for microvascular invasion in hepatocellular carcinoma: where do we stand?
    Gouw AS; Balabaud C; Kusano H; Todo S; Ichida T; Kojiro M
    Liver Transpl; 2011 Oct; 17 Suppl 2():S72-80. PubMed ID: 21714066
    [No Abstract]   [Full Text] [Related]  

  • 12. Milan criteria in liver transplantation for hepatocellular carcinoma: an evidence-based analysis of 15 years of experience.
    Mazzaferro V; Bhoori S; Sposito C; Bongini M; Langer M; Miceli R; Mariani L
    Liver Transpl; 2011 Oct; 17 Suppl 2():S44-57. PubMed ID: 21695773
    [No Abstract]   [Full Text] [Related]  

  • 13. Which matters most: number of tumors, size of the largest tumor, or total tumor volume?
    Germani G; Gurusamy K; Garcovich M; Toso C; Fede G; Hemming A; Suh KS; Weber A; Burroughs AK
    Liver Transpl; 2011 Oct; 17 Suppl 2():S58-66. PubMed ID: 21584928
    [No Abstract]   [Full Text] [Related]  

  • 14. Imaging diagnosis and staging of hepatocellular carcinoma.
    Lee JM; Trevisani F; Vilgrain V; Wald C
    Liver Transpl; 2011 Oct; 17 Suppl 2():S34-43. PubMed ID: 21739567
    [No Abstract]   [Full Text] [Related]  

  • 15. Summary of candidate selection and expanded criteria for liver transplantation for hepatocellular carcinoma: a review and consensus statement.
    Prasad KR; Young RS; Burra P; Zheng SS; Mazzaferro V; Moon DB; Freeman RB
    Liver Transpl; 2011 Oct; 17 Suppl 2():S81-9. PubMed ID: 21748847
    [No Abstract]   [Full Text] [Related]  

  • 16. Liver transplantation for hepatocellular carcinoma: Foucault pendulum versus evidence-based decision.
    Bruix J; Fuster J; Llovet JM
    Liver Transpl; 2003 Jul; 9(7):700-2. PubMed ID: 12827556
    [No Abstract]   [Full Text] [Related]  

  • 17. General overview of neo-adjuvant therapy for hepatocellular carcinoma before liver transplantation: necessity or option?
    Fujiki M; Aucejo F; Kim R
    Liver Int; 2011 Sep; 31(8):1081-9. PubMed ID: 22008644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular Carcinoma Progression While on Waiting List for Liver Transplantation.
    Giacomoni A; Concone G; Di Sandro S; Lauterio A; De Carlis L
    Transplantation; 2015 Sep; 99(9):e155-6. PubMed ID: 26308419
    [No Abstract]   [Full Text] [Related]  

  • 19. Selection of candidates with HCC for transplantation in the MELD era.
    Sala M; Varela M; Bruix J
    Liver Transpl; 2004 Oct; 10(10 Suppl 2):S4-9. PubMed ID: 15382217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanded criteria for hepatocellular carcinoma through down-staging prior to liver transplantation: not yet there.
    Llovet JM; Schwartz M; Fuster J; Bruix J
    Semin Liver Dis; 2006 Aug; 26(3):248-53. PubMed ID: 16850374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.